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Objectives: Cadmium (Cd) toxicity of the kidney varies between individuals despite similar exposure levels. In
humans Cd is mainly bound to metallothioneins (MT), which scavenge its toxic effects. Here we analyzed
whether polymorphisms in MT genes MT1A and MT2A inﬂuence Cd-related kidney damage.
Methods: In a cross-sectional study N=512 volunteers were selected from three areas in South-Eastern China,
which to varying degreewere Cd-polluted froma smelter (control area [median Cd in urineU-Cd=2.67 μg/L],mod-
erately [U-Cd=4.23 μg/L] and highly [U-Cd=9.13 μg/L] polluted areas). U-Cd and blood Cd (B-Cd) concentrations
weremeasuredby graphite-furnace atomic absorption spectrometry.MT1A rs11076161 (G/A), MT2A rs10636 (G/C)
and MT2A rs28366003 (A/G) were determined by Taqman assays; urinary N-Acetyl-beta-(D)-Glucosaminidase
(UNAG) by spectrometry, and urinary β2-microglobulin (UB2M) by ELISA.
Results:Higher B-Cd (natural log-transformed) with increasing number ofMT1A rs11076161 A-alleles was found in
the highly polluted group (p-value trend=0.033; all p-values adjusted for age, sex, and smoking). In a linearmodel
a signiﬁcant interaction between rs11076161 genotype and B-Cd was found for UNAG (p=0.001) and UB2M con-
centrations (p=0.001). Carriers of the rs11076161 AA genotype showed steeper slopes for the associations be-
tween Cd in blood and natural log-transformed UB2M (β=1.2, 95% CI 0.72–1.6) compared to GG carriers (β=
0.30, 95% CI 0.15–0.45). Also for UNAG (natural log-transformed) carriers of the AA genotype had steeper slopes
(β=0.55, 95% CI 0.27–0.84) compared to GG carriers (β=0.018, 95% CI−0.79–0.11).
Conclusions: MT1A rs11076161 was associated with B-Cd concentrations and Cd-induced kidney toxicity at high
exposure levels.© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Long-term exposure to the environmental pollutant cadmium (Cd)
damages the kidneys. It causes renal tubular dysfunction as assessed
by increased urinary excretion of low molecular weight proteins, such
as α1-microglobulin, β2-microglobulin (UB2M) and N-Acetyl-beta-; ELISA, Enzyme linked im-
ymerase chain reaction; SNP,
microglobulin; U-Cd, Urinary
nidase.
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NC-ND license.(D)-Glucosaminidase (UNAG; Jin et al., 1999, 2002; Nogawa et al.,
1984). Once absorbed Cd is efﬁciently retained in the organism and
accumulates throughout life with a biological half-time of 10–30 years
in humans (Nordberg et al., 2007). Metallothioneins (MTs) are low
molecular weight proteins involved in the homeostasis of zinc. Their
transcription is induced by various heavy metals, such as Cd. In the
cell, over 80% of Cd is bound to MT and MTs play a considerable role
in the shift of accumulated Cd from the liver and intestines to the kidney
(Nordberg et al., 2007).
Intracellular binding of Cd to MTs offers protection against cellular
damage (Jin et al., 1998). Transgenic mice constantly over-expressing
MT genes are also Cd-tolerant (Palmiter et al., 1993). In contrast,
knockout mice with defective MT genes are more sensitive to Cd
toxicity than wild-type mice (Jin et al., 1998; Liu et al., 2000). In
MT-deﬁcient mice, renal dysfunction can be detected even at renal
concentrations of Cd below 10 μg/g tissue (Liu et al., 2000). The ﬁnd-
ings of many similar studies support the notion that MT is the main
cellular determinant of the sensitivity of mammals and cultured
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cells in a low-toxicity state (Klaassen et al., 1999), and kidney dysfunc-
tion occurs when tissue levels exceed the capacity of this protective
mechanism. If MT synthesis is decreased or inhibited, then serious
renal dysfunction might develop in individuals with high concentra-
tions of Cd. In previous studies, it was found that at similar urinary Cd
values, workers with high levels of MT mRNA in peripheral blood
lymphocytes had lower UNAG levels than those with low MT mRNA
levels (Lu et al., 2001). These ﬁndings suggest that individuals with
reduced expression of MT might be prone to renal dysfunction due to
exposure to Cd.
The MT genes are in a cluster on chromosome band 16q13. Two of
the main MTs widely expressed in the body are MT1A and MT2A
(Klaassen et al., 1999). Several single nucleotide polymorphisms
(SNPs) (rs8052394 and rs11076161 in the MT1A gene, and rs10636
in MT2A gene) have been reported to be involved in aging, diabetes
and atherosclerosis, probably reﬂecting their role in zinc homeostasis
(Giacconi et al., 2007; Kayaalti et al., 2010; Kita et al., 2006; Mazzatti
et al., 2008; Mocchegiani et al., 2008). Of these polymorphisms, rs80
52394 is non-synonymous (Arg51Lys), while rs11076161 is intronic
and rs10636 is located in the 3′ untranslated region (http://www.ncbi.
nlm.nih.gov/snp/). Kita et al. (2006) demonstrated an effect of MT2A
rs28366003 on expression levels in response to Cd and Zn exposure in
vitro. The polymorphism is located in the promoter region and cultured
human kidney cells transfected with the rs28366003 G/G genotype
respondedwith lower transcription efﬁciency to Cd exposure compared
to cells transfected with the A/A genotype.
While there are a number of polymorphisms inMT1A andMT2A, the
minor allele frequency of themajority is low or unknown (http://www.
ncbi.nlm.nih.gov/snp/). Variation ofMT1A is described by three tagging
SNPs, one of them is rs11076161, carrying information about variation
in a larger genomic region (http://hapmap.ncbi.nlm.nih.gov/index.
html.en). In MT2A, only rs10636 and rs28366003 have minor allele
frequency above 5%, which is suitable for gene–environment interac-
tion analysis of medium size. However, it is not yet clear if these SNPs
maymodify Cdmetabolism and Cd-induced excretion of lowmolecular
weight proteins in vivo.
Our aim was to elucidate how variations in MT genes affect the
metabolism of Cd and Cd-induced excretion of low molecular weight
proteins. Therefore, inhabitants from areas to a varying extent pollut-
ed by Cd in South-Eastern China were genotyped for SNPs in MT1A
(rs11076161) and MT2A (rs10636 and rs28366003).
Methods
Study subjects. A cross-sectional study was performed in South-
Eastern China in 2006 among persons with a history of Cd exposure
through contaminated rice which is the main food consumed in this
region (Jin et al., 1999, 2002). The subjects included lived in either a
Cd-polluted area near a non-ferrous metal smelter or in a control area
at 40 km from the smelter. Cd levels in rice in the contaminated areas,
i.e. Jiaoweibao (highly polluted) were 3.7 mg Cd/kg in rice on average,
in Nanbaixiang (moderately polluted) 0.5 mg Cd/kg in rice, and these
levels were higher than the State Hygienic Standard (0.2 mg Cd/kg).
Yantuo (control area) demonstrated 0.072 mg Cd/kg in rice on average.
In 1996, the residents of the Cd-contaminated areas were asked to stop
producing rice in their own ﬁelds and to eat commercial rice from
non-polluted areas (0.03 mg Cd/kg).
Based on registry information available from the local authorities,
the characteristics of the populations (such as age, sex distribution
and birth rate) were available for the three areas (highly polluted,
moderately and control area). Data from nutrition surveys performed
in the period after 1960 were collected and present nutritional status
was assessed by means of a targeted interview of 10 families in each
area. Participants were selected based on this information to ensure
that living conditions, social and economic conditions, and lifestyleswere similar in all areas. Only persons born in the respective areas
who had lived there and consumed locally grown rice throughout
their entire lifetime (apart from the years when the local rice was
banned) were included in the present study. In 2006 a number of
512 residents were included in the study, divided into N=255 living
in the highly polluted area, N=137 in the moderately polluted area
and N=120 in the control area.
The study subjects gave their informed written consent to take
part in the study. The study was approved by the Ethical Committee
of Public Health School at the Fudan University, Shanghai, China.
Sample collection and analysis. Cd in blood (B-Cd) is a marker of ongo-
ing exposure (last 2–3 months and partly life-long exposure) whereas
Cd in urine (U-Cd) is a marker of life-long exposure (Järup and
Åkesson, 2009). UB2M and UNAG are very sensitive markers of tubular
kidney damage and increased excretion can be detected long before
the kidney damage is considered clinically relevant (Chaumont et al.,
2012; Liang et al., 2012).
Following a strict sampling protocol (Jin et al., 1999, 2002), spot urine
sampleswere collected from each subject inmetal-free polyethylene bot-
tles which had been washed with diluted nitric acid followed
by de-ionized water and stored at −20 °C until analysis. Each urine
sample was divided into four parts immediately by pouring after collec-
tion. Of those, the ﬁrst was acidiﬁed with concentrated nitric acid for
assay of Cd; the second was made alkaline for assay of UB2M; the
others were used to determine creatinine, and UNAG (UALB) without
pretreatment. A total of 2 mL of venous whole blood was collected in a
heparin-containing Vacutainer: 1 mL samplewas taken for B-Cd analyses
and stored at−70 °C until analysis, and from 1 mL DNA was extracted.
U-Cd and B-Cd concentrationsweremeasured by graphite-furnace atom-
ic absorption spectrometry using standard addition as described (Jin et al.,
1999, 2002). A reference urine sample (Seronorm trace elements urine,
Nycomed, Oslo, Norway) was inserted in each run of 10 samples. UB2M
was assessed using the enzyme linked immunoabsorbent assay (ELISA)
method, with kits purchased from the China Institute of Atomic Energy,
China. UNAG was analyzed by spectrophotometry (Price, 1992). Creati-
nine was determined by the Jaffe reaction method (Hare, 1950). All
urine parameters were standardized to the concentration of creatinine
in urine. For quality assurance, analyses were conducted by the same
trained investigators and with consistent methods by the same techni-
cians in the same laboratories.
Genotype analyses. Genomic DNA was extracted using QIAamp blood
DNA mini kits (QIAGEN, Hilden, Germany). SNPs were selected from
the literature based on reported association with zinc status or disease,
and checked forminor allele frequency: SNPswithminor allele frequen-
cy b5% in Asian populations (based on information fromwww.hapmap.
org) being excluded. We used Taqman allelic discrimination assays
(Applied Biosystems, Foster City, CA, USA) to separately analyze three
SNPs: MT2A (rs10636 and rs28366003) and MT1A (rs11076161). Each
real-time polymerase chain reaction (PCR) assay was performed with
a reaction volume of 5 μL containing 1×Universal Taqmanmix (Applied
Biosystems), 1 ng DNA, 0.4 μM of each primer, and 0.1 μM of each
probe, using the following program: 95 °C for 10 min, followed by
40 cycles of 95 °C for 15 s and 60 °C for 1 min (ABI 7900; Applied
Biosystems). Quality was assured by including controls for each geno-
type, as well as negative controls, in each run, and repeating the
genotyping on 5% of the samples. There was a perfect agreement be-
tween the original and repeat genotype runs for all three SNPs analyzed.
Statistical analysis. Deviations from Hardy–Weinberg equilibrium
were tested using the Chi square (χ2) test. In order to fulﬁl the
criteria for parametric analysis, B-Cd, U-Cd and the biomarkers for
renal dysfunction: UNAG, UB2M, and UALB were natural log-
transformed. Each polymorphism was modeled as a categorical vari-
able (zero, one, or two variant alleles). When the frequency of a
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the heterozygotes.
To explore the inﬂuence of MT polymorphisms on B-Cd and U-Cd
at different levels of exposure, subjects were analyzed according to
level of Cd pollution (high, moderate, and low). Analysis of variance
(ANOVA) was employed to analyze, within the different exposure
groups, the effects of genotype of each polymorphism on ln(B-Cd)
or ln(U-Cd), as the dependent variables. Adjustments were made
for other potentially inﬂuential variables (age, sex, and smoking). To
account for multiplicative effect modiﬁcation, a multivariate model
was used with an interaction term between exposure group and
genotype for ln(B-Cd) and ln(U-Cd) (both variables entered as cate-
gorical variables).
To analyze the inﬂuence of MT polymorphisms on the association
between Cd exposure and excretion of low molecular weight pro-
teins, ANOVA was employed to analyze, within the different exposure
groups, the effects of genotype of each polymorphism on ln(UNAG),
ln(UB2M) or ln(UALB) as the dependent variables. Adjustments were
made for other potentially inﬂuential variables (age, sex, and smoking).
We then analyzed multiplicative effect modiﬁcation in a multivariate
model with an interaction term between ln(B-Cd/U-Cd) and genotype
with ln(UNAG), or ln(UB2M) as dependent variables. For those analyses
that demonstrated a signiﬁcant interaction between genotype and
ln(B-Cd) or ln(U-Cd), the analysis was stratiﬁed for genotype to obtain
effect measures for different genotypes.
Further, the inﬂuence of MT SNPs on the risk of having affected
kidney function (measured as having UB2M or UNAG concentrations
above 95th percentile of UB2M or UNAG concentrations of individuals
from the control area (b80 years)) was analyzed for individuals living
in the medium and highly polluted areas. The strength of the associ-
ations between genotypes and risk of affected kidney function was
estimated as odds ratios with 95% conﬁdence intervals (CIs) by un-
conditional logistic regression.
All statistical analyses were performed using SPSS software (version
15; SPSS, Chicago, IL, USA). Statistical signiﬁcance refers to pb0.05.
Results
Demographic and genetic data of the study population
The characteristics of the study subjects are shown in Table 1. There
were 32.8% men and 66.2% women in the total study population, andTable 1
Characteristics of the study subjects.a
Variables Control area (N=137) Moderatly poll
Ageb 65 (44–83) 54 (43–74)
Sex (N) male/female 43/94 41/79
Smoking (N) never/former/current 108/6/23 98/1/21
B-Cd (μg/L)b, c 0.96 (0.22–2.93) 2.03 (0.59–2.54
Male 1.46 (0.14–5.2) 1.83 (0.45–5.35
Female 0.90 (0.24–2.49) 2.11 (0.63–5.66
U-Cd (μg/gCr)b,c 2.67 (0.70–7.62) 4.23 (1.30–12.1
Male 2.69 (0.85–7.99) 3.63 (0.93–13.8
Female 1.65 (0.35–6.43) 4.59 (0.56–10.9
UNAG (U/gCr)b,c 8.9 (4.5–22.4) 8.52 (4.32–21.7
Male 7.56 (4.42–20.1) 7.64 (4.23–21.5
Female 9.34 (4.46–26.4) 9.00 (4.32–22.3
UB2M (mg/gCr)b,c 0.16 (0.037–1.8) 0.25 (0.10–1.20
Male 0.16 (0.05–2.14) 0.25 (0.12–1.14
Female 0.16 (0.03–1.71) 0.25 (0.07–1.69
a There was missing information to a varying extent (total N with information=499–51
b The values presented are median (5–95th percentiles).
c The abbreviations used were B-Cd = blood cadmium; U-Cd = urinary cadmium; UNAG83% of the subjects were non-smokers, 3% former smokers, and 14%
smokers. The median age of the subjects from the control area was
7–10 years higher than the median age from the other two areas
(p-value Kruskal–Wallis-test b0.001). Median levels of B-Cd and U-Cd
increased from low to high exposure groups, and the same trends
were seen for all kidney markers apart from UNAG, where low and
moderate exposure groups demonstrated similar median levels. Thus,
the genetic association studieswere based on exposure groups. Howev-
er, as there was an overlap between the B-Cd values among the groups,
in an alternative approach the subjects were grouped by B-Cd tertiles.
The cut-off values were 1.7 μg/L and 3.2 μg/L. Thus, there were N=
174 in the lowest, N=164 in the middle, and N=173 in the highest
tertile.
The genotype and allele frequencies of MT1A rs11076161, MT2A
rs10636 and MT2A rs28366003 were tabulated in Table 2. All three
SNPs demonstrated allele frequencies >5%. The Chi square (χ2) test
showed that the genotypic distributions of all three SNPs did not
deviate from the Hardy–Weinberg equilibrium (p>0.05).Association between MT SNPs and Cd exposure biomarkers
First, the impact of genotype on the B-Cd concentrationwas evaluat-
ed in each exposure group. ForMT1A rs11076161 andMT2A rs10636, an
allele-dosage effect could be observed (Fig. 1, and Supplementary Fig. 1)
where variant genotypes showed slightly higher B-Cd levels in the
moderate and the high exposure groups. There were very few (≤10)
variant homozygotes for MT2A rs28366003 and the variant genotypes
(GG and AG) were thus combined. The variant genotypes for MT2A
rs28366003 demonstrated higher B-Cd levels as well, also in the low
exposure group (Supplementary Fig. 2). The trend for higher B-Cd
with increasing number of variant alleles was signiﬁcant for MT1A
rs11076161 in the high exposure group (p-value=0.032 unadjusted;
p-value=0.033 adjusted for sex, age and smoking). P-values for trend
in the other exposure groups were p>0.1. A non-signiﬁcant trend
was also seen for MT2A rs28366003 in the low exposure group
(unadjusted p-value=0.099; adjusted p-value=0.075). In the analysis
grouped by B-Cd tertiles, the trend for increased B-Cd with increasing
number of variant alleles of rs11076161 became more pronounced in
the middle tertile (p-value for trend=0.001 both, unadjusted and
adjusted for age, sex, and smoking). The trends for rs10636 and rs28
366003 disappeared.uted (N=120) Highly polluted (N=255) Total population (N=512)
57 (44–78) 57.5 (44–79)
86/169 170/342
219/10/26 425/17/70
) 3.66 (1.05–9.27) 2.33 (0.45–7.91)
) 3.76 (0.98–10.8) 2.53 (0.47–7.07)
) 3.51 (1.13–9.33) 2.31 (0.44–8.22)
) 9.13 (2.81–25.0) 5.38 (1.24–19.9)
) 10.6 (2.60–28.0) 5.12 (1.06–22.3)
) 11.9 (2.59–36.0) 5.75 (0.57–25.3)
) 12.1 (4.0–46.4) 9.85 (4.25–34.3)
) 12.1 (3.58–87.7) 8.58 (4.03–46.8)
) 12.1 (4.19–37.0) 10.2 (4.32–30.7)
) 0.39 (0.09–4.8) 0.28 (0.07–3.5)
) 0.40 (0.08–6.50) 0.26 (0.07–4.06)
) 0.39 (0.1–4.37) 0.28 (0.07–3.22)
2 depending on variable), due to lack of material for analysis, or analysis failure.
= urinary N-Acetyl-beta-(D)-Glucosaminidase; UB2M = urinary β2-microglobulin.
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Table 2
Distribution of metallothionein genotypes and allele frequencies.
Gene/SNP Numbera Alleles and
genotypes
HWEb
n %
MT1A rs11076161
N=511
A 33.7 0.006
G 66.3
AA 54 11
AG 236 46
GG 221 43
MT2A rs10636
N=505
C 29.3 0.028
G 70.7
CC 50 10
CG 196 39
GG 259 51
MT2A rs28366003
N=512
G 13.1 0.023
A 86.9
GG 10 2
AG 114 21
AA 388 77
a Number of individuals successfully genotyped.
b HWE = Hardy–Weinberg equilibrium presented as the χ2-value.
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difference between the adjusted R2 for rs11076161 only (0.06) com-
pared to the model including age, sex and smoking as well (0.07).
Secondly, the same analysis was performed for U-Cd, but no clear
allele dosage effect forMT1A rs11076161 orMT2A rs10636 was found
(data not shown). ForMT2A rs28366003, a non-signiﬁcant but similar
pattern as for B-Cd was seen for all exposure groups (data not shown).
When analyzing the genetic impact on U-Cd by B-Cd tertiles instead,
rs11076161 was signiﬁcantly associated with U-Cd in the highest
tertile: for increasing U-Cd with increasing number of variant alleles
the p-value for trend was 0.01 in the unadjusted model and p=0.001
for the model adjusted for age, sex and smoking.
There was no interaction (p>0.05) between exposure and geno-
type for B-Cd and U-Cd: the mean differences between the genotypes
were similar in each exposure group (Fig. 1, Supplementary Figs.
1–2).Cadmium exposure groups
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Fig. 1. Blood cadmium (natural log transformed) in the three exposure groups strati-
ﬁed for genotype ofMT1A rs11076161. P-values (trend) for association between geno-
type and ln B-Cd in each exposure group were p=0.42 (control area), p=0.42
(moderately polluted) and p=0.033 (highly polluted); adjusted for age, sex, and
smoking status. The data points represent the mean, and the uncertainty bars the
95% CI.Effect modiﬁcation of MT polymorphisms on Cd-related levels of UNAG
and UB2M
First, genetic effect modiﬁcation on Cd-related excretion of low mo-
lecular weight proteins was evaluated in different exposure groups. For
rs11076161, the genotype was signiﬁcantly (p-value=0.045, adjusted
for age, sex and smoking) associated with UNAG in the highly polluted
group: the variant homozygotes demonstrated the highest levels of
UNAG (Fig. 2A). The same pattern was seen for UB2M (p=0.052;
Fig. 2B). The same pattern, but non-signiﬁcant, was seen for rs10636
(Supplementary Figs. 3a and b; UB2M p=0.28 in the high exposure
group;UNAGp=0.13), but no effect of rs28366003was found. In the al-
ternative analyses by B-Cd tertiles, the genetic inﬂuence of rs11076161
became more obvious in the highest tertile on UNAG (p-value=0.01)
and UB2M (p-value=0.002; both p-values for trends in models adjust-
ed for age, sex and smoking). In the models stratifying for B-Cd tertiles
instead of exposure groups, associations of the other two SNPs with
UNAG and UB2M disappeared.
Secondly, genetic effect modiﬁcation on Cd-related levels of UNAG
and UB2Mwas evaluated by using Cd in blood or in urine as exposure
markers. The four exposure–response marker combinations that had
signiﬁcant or nearly signiﬁcant interaction p-values in Table 3 were se-
lected for calculation of genotype-speciﬁc association coefﬁcients which
are presented in Table 4. Coefﬁcients of non-signiﬁcant associations are
presented in Supplementary Table S1. There was a signiﬁcant interaction
of MT1A rs11076161 with B-Cd (adjusted p=0.001), as well as weakly
with U-Cd (adjusted p=0.062, unadjusted p=0.053) for concentrations
of UB2M (Table 3). Carriers of the variant genotype AA demonstrated
a steeper slope for the association between B-Cd/U-Cd and UB2M0
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Fig. 2. A–B Histograms depicting the median A) UB2M and B) UNAG in different Cd
exposure groups stratiﬁed for genotype of MT1A rs11076161.
Table 3
Inﬂuence of genetic variation on the associations between Cd exposure and biomarkers of renal dysfunction.a
Biomarker/SNP p-value B-Cd p-value genotype p-value interaction p-value U-Cd p-value genotype p-value interaction
UNAG/rs11076161 0.061 b0.001 0.66 0.37
b0.001 (0.039)b (b0.001)b b0.001 (0.71)b (0.28)b
UNAG/rs10636 0.16 0.67 0.40 0.22
0.003 (0.17) (0.77) b0.001 (0.54) (0.16)
UNAG/rs28366003 0.42 0.73 0.19 0.018
b0.001 (0.52) (0.67) b0.001 (0.14) (0.013)
UB2M/rs11076161 0.16 0.001 0.015 0.062
b0.001 (0.11) (0.001) b0.001 (0.027) (0.053)
UB2M/rs10636 0.15 0.79 0.67 0.24
b0.001 (0.11) (0.86) b0.001 (0.76) (0.20)
UB2M/rs28366003 0.029 0.47 0.94 0.22
b0.001 (0.041) (0.52) b0.001 (0.97) (0.18)
a p-values for natural log-transformed Cd in blood, genotype coefﬁcients (coded as categorical variables) and interaction coefﬁcients (genotype×B-Cd) from multivariate regres-
sion models for natural log-transformed UNAG or UB2Mwith adjustment for the following covariates: sex, age, and smoking (results from the latter not presented in the table). The
same model was used with natural log-transformed U-Cd as exposure marker.
b p-values for natural log-transformed Cd exposure biomarkers, genotype coefﬁcients (coded as categorical variables) and interaction coefﬁcients (genotype×B-Cd) from mul-
tivariate regression models with natural log-transformed UNAG or natural log-transformed UB2M as outcomes. The same model was used with natural log-transformed U-Cd as
exposure marker.
2.5   MT1A
377L. Lei et al. / Toxicology and Applied Pharmacology 265 (2012) 373–379compared to carriers of genotype GG (Table 4). A signiﬁcant interaction
with rs11076161 and B-Cd, but not with U-Cd was found for UNAG con-
centrations. Carriers of the variant genotype AA were associated with a
steeper slope for the association between B-Cd and UNAG compared to
carriers for genotypes AG or GG (Table 4; Fig. 3). Rs28366003 modiﬁed
the association between U-Cd and UNAG, where individuals carrying
the variant genotype demonstrated a shallower slope compared to the
common genotype. Although therewere only 10 carriers of the GG geno-
type, we analyzed whether they had even higher UNAG levels in relation
to U-Cd levels compared to the heterozygotes. However, for the few GG
carriers the ß-coefﬁcient was −0.06 (95% CI −0.8 to 0.6) compared to
heterozygotes (ß-coefﬁcient 0.18; 95% CI 0.04 to 0.3).
The threshold for having affected kidney functionwas based on 95th
percentile of UB2M and concentrations of the individuals in the control
area (corresponding to 1.49 mg/gCr UB2M and 20.3 U/gCr UNAG) for
persons younger than 80 years. With this threshold 12.3% (N=46) of
the individuals in the medium and highly polluted areas had affected
kidney function measured as UB2M and 15% (N=56) measured as
UNAG. Carriers of rs11076161 variant genotypes (AA/AG) had an odds
ratio of 2.8 (95% CI 1.4–5.8; P=0.004) for UB2M above threshold com-
pared to carriers of the GG genotype (adjusted for U-Cd; odds ratio=3.3
(95% CI 1.5–7.2; P=0.003, adjusted for U-Cd, sex, age, and smoking).
None of the other SNPs affected the risk of having affected kidney
function measured as increased levels of UB2M or UNAG.Table 4
The associations between exposure biomarkers for Cd and markers of renal dysfunc-
tion, UNAG and UB2M, stratiﬁed for genotype.a
Exposure
marker
Biomarkers of renal
dysfunction/genotype
Genotype ß-coefﬁcient 95% CI
B-Cd UNAG/ AA 0.55 0.27–0.84
rs11076161 AG 0.15 0.063–0.24
GG 0.018 −0.079–0.11
B-Cd UB2M/ AA 1.2 0.72–1.6
rs11076161 AG 0.45 0.29–0.61
GG 0.30 0.15–0.45
U-Cd UB2M/ AA 0.57 0.27–0.87
rs11076161 AG 0.70 0.52–0.88
GG 0.39 0.23–0.54
U-Cd UNAG/ GG+AG 0.16 0.029–0.30
rs28366003 AA 0.33 0.26–0.40
a Linear regression analysis was performed with either natural log-transformed
cadmium in blood (B-Cd) or cadmium in urine (U-Cd), age, sex and smoking status
as dependent variables and markers of renal dysfunction as outcomes (natural
log-transformed), stratiﬁed for each genotype.Discussion
Despite the known individual susceptibility of Cd toxicity, strik-
ingly little is known about the role of our genetic background for Cd
sensitivity. Here we have identiﬁed a genetic marker that modiﬁes
Cd-associated renal toxicity: with elevating Cd concentration the
MT1A rs11076161 AA carriers demonstrated the highest concentra-
tions of UNAG and UB2M in urine. Also, we found a relationship be-
tween the MT1A rs11076161 AA genotype and B-Cd at high Cd
exposures.
One major strength is that the Cd exposure varies widely within this
study: B-Cd ranged between 0.11 and 21, U-Cd between 0.05 and
75 μg/L. We analyzed UNAG and UB2M, which are very sensitive bio-
markers of renal tubular damage (Bernard, 2004). Furthermore, the
study populationwas ethnically homogenous, and the study participants
were recruited so that living conditions, social and economic conditions
and lifestyles were similar in the different areas. The genotyping was
done with Taqman assays that are less prone to errors compared to
restriction fragment length polymorphism analysis and quality control
was strict. To our knowledge no other studies were performed of an ap-
propriate study size suitable for genetic association studies with bothB-Cd (natural log transformed)
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Fig. 3. Association between UNAG and B-Cd (both natural log transformed) by geno-
type of MT1A rs11076161.
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the classiﬁcation in exposure groups in the statistical analyses. However,
as there was an overlap of B-Cd concentrations between the groups, the
subjects were also grouped by B-Cd tertiles and in each tertile the associ-
ations between genotype and B-Cd, U-Cd, UNAG and UB2Mwere evalu-
ated. This strengthened the associations for rs11076161.
In this study multiple testing was performed: 3 polymorphisms
and 4 outcomes were included in several multivariate regression
models. Thus, there might problems with false positive ﬁndings.
According to Wacholder et al. (2004) the false positive report proba-
bility is inﬂuenced by the signiﬁcance level, statistical power and
prior probability of the association tested. As the selection of the poly-
morphisms was based on evidence from other studies, which gives
high prior probability, we assume that the false positive report prob-
ability was low. However, follow-up studies are needed to conﬁrm
our ﬁndings.
Study participants in the highly contaminated area had not
consumed local rice for the ten years before 2006, when this study
was conducted. Therefore, much of the Cd burden in this group was
ten years old, which by some estimates is the half-life for Cd in the
kidney. Thus, U-Cd in this group might underestimate the actual
exposure and consequently the contribution of Cd toxicity to excre-
tion of low molecular weight proteins (Nordberg et al., 2012). Since
the median age of the subjects from the control area was higher,
and thus, the contribution of aging on kidney damage probably was
higher, this might add to underestimation of the effects caused by Cd.
The 95th percentile used for identifying subjects with abnormal
UB2M excretion (1.49 mg/gCr) was slightly higher than what was
reported in similar studies by Liang et al. (2012) (1.028 mg/gCr)
and Wu et al. (2008) (0.8 mg/gCr). However, the latter study popula-
tion was slightly younger than ours. For UNAG we used 20.3 U/gCr
compared to 16.6 U/gCr in Liang et al. (2012). In our comparison
slightly higher cut-off value probably avoids overestimation of the
genetic effect, since kidney damage at lower levels is attributed to
other factors than those related to genetics.
TheMT1A rs11706161 genotype showed a modifying effect on the
excretion of UB2M and UNAG, the strongest was seen for B-Cd and
UNAG where over 20× steeper slope was found between AA carriers
compared to the GG carriers. These results indicate that the A allele
may carry the main responsibility for the dependence of UNAG on
B-Cd. For UB2M the effect was weaker: 4× steeper slope between
AA carriers compared to the GG carriers.
We could not ﬁnd other reports about the modifying effects of
MT1A polymorphisms on Cd metabolism or Cd toxicity. In one
study, MT1A rs11076161 was signiﬁcantly related to the occurrence
of diabetic neuropathy in the type 2 diabetes mellitus patients, but
which of the allele is at risk was not presented (Yang et al., 2008).
At basal level, the MT2A isoform is expressed more than the MT1 iso-
form, due to the enhancer activity in theMT2A (Haslinger and Karin,
1985). While the MT2A promoter responds to zinc, copper, Cd and
glucocorticoids, for MT1, response has so far only been shown for
Cd (Andrews, 2000). Li et al. (2005) showed that MT1A was more ef-
ﬁcient than MT2 in providing resistance to Cd in HEK293 cells
(10 μM). This difference in response to Cd between MT1A and
MT2A may explain that MT1A had a stronger modifying effect on
Cd metabolism and toxicity compared to SNPs in MT2A.
None of the SNPs analyzed were coding SNPs, and therefore they
were analyzed bioinformatically through the Genomatix database
(www.genomatix.de) for potential binding sites for transcription fac-
tors regulating gene expression. The G allele ofMT1A rs11076161 cre-
ates a binding site for ZBTB16 (or PLZF), which is a zinc ﬁnger protein
involved in histone modiﬁcation (Spicuglia et al., 2011). The G allele of
MT2A rs10636 abolishes a binding site for DREAM, a calcium-regulated
transcriptional repressor (Carrion et al., 1999); and creates one for
EKLF, which is involved in transcriptional regulation in erythroids
(Donze et al., 1995). The G allele of MT2A rs28366003 abolishes abinding site for MTF1, a transcription factor that is known to induce
gene expression in response to Cd.
The frequency of the rs11076161 A allele among Europeans (0.26)
is estimated to be lower than in the Chinese population, whereas it is
higher among Africans (0.52) (www.ncbi.nlm.nih/projects/SNP),
suggesting that differences in susceptibility to renal toxicity between
different populations could be expected.
The ﬁnding of a relationship between B-Cd andMT1A rs11076161
makes it difﬁcult to distinguish whether the genotype affects the Cd
body burden, or if it has a speciﬁc effect on Cd in blood. Genotype
speciﬁc expression of MT1A caused by presence/absence of a ZBTB16
transcription signal could be the underlying mechanism that explains
why AA/AG carriers are at higher risk to develop affected kidney func-
tion upon exposure to Cd. More studies will be needed to verify the
effect of rs11076161 genotypes on Cd-induced renal toxicity. An ideal
way would be to obtain cell lines that differ in rs11076161 genotype
and study their cadmium sensitivity.
The MT2A rs28366003 genotype seemed to have a slight effect on
the B-Cd levels, which was more evident in the low exposure group.
However, when considering B-Cd in tertiles, there was no effect of
this SNP on the Cd concentrations and we could not support evidence
from other studies. The variant genotype GG was associated with
increased concentrations of Cd in the kidney tissue from autopsies
(Kayaalti et al., 2010; Kita et al., 2006) and blood (Kayaalti et al.,
2011). Kita et al. (2006) demonstrated a reduced expression of this
G variant in response to Cd and Zn exposure, and thus, one could
expect that G carriers would suffer more toxic effects of Cd. However,
the latter could not be supported in our study. Rather the opposite
was observed; G carriers had lower levels of UNAG in urine.
In conclusion, this study identiﬁes that the rs11076161 G→A
exchange of MT1A inﬂuences the toxicity of Cd on renal function:
AA genotype may be more sensitive to cadmium toxicity than those
with the GG genotype. It suggests that MT1A variation may be an
additional useful indicator to monitor for prediction of the risk of
renal dysfunction in certain populations.
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